- Marinomeds distribution partner M8 Pharmaceuticals obtained market approval for distribution and marketing of a Carragelose nasal spray in Mexico
- Launch of the product under the trade name Barlo® is planned for the upcoming season
- Promising Mexican OTC (over-the-counter) cough & cold market holds significant Carragelose revenue potential
The full press release is available as download here: